Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-06-11 @ 10:12 AM
Study NCT ID:
NCT04604067
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-28
First Post:
2020-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
Sponsor:
Swiss Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diffuse Large B-cell Lymphoma | View |